GRP
IONS icon

Global Retirement Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Global Retirement Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$148K Buy
1,876
+1,853
+8,057% +$140K ﹤0.01% 1659
2025
Q3 		$1.5K Buy
23
+7
+44% +$342 ﹤0.01% 3404
2025
Q2 		$632 Buy
+16
New +$524 ﹤0.01% 3544
2024
Q4 		$2.52K Sell
72
-29
-29% -$1.08K ﹤0.01% 2987
2024
Q3 		$4.05K Buy
101
+3
+3% +$140 ﹤0.01% 2663
2024
Q2 		$4.67K Buy
98
+4
+4% +$164 ﹤0.01% 2645
2024
Q1 		$4.08K Buy
94
+3
+3% +$143 ﹤0.01% 2480
2023
Q4 		$4.64K Buy
91
+33
+57% +$1.58K ﹤0.01% 2350
2023
Q3 		$2.53K Hold
58
– – ﹤0.01% 2447
2023
Q2 		$2.38K Hold
58
– – ﹤0.01% 2476
2023
Q1 		$2.01K Buy
58
+7
+14% +$263 ﹤0.01% 2505
2022
Q4 		$1.93K Hold
51
– – ﹤0.01% 2378
2022
Q3 		$2K Sell
51
-20,380
-100% -$859K ﹤0.01% 2253
2022
Q2 		$756K Buy
20,431
+90
+0.4% +$3.39K 0.06% 288
2022
Q1 		$755K Buy
+20,341
New +$666K 0.06% 290
2021
Q4 		– Sell
-5,784
Closed -$194K – 999
2021
Q3 		$194K Buy
5,784
+471
+9% +$17.7K 0.02% 475
2021
Q2 		$212K Buy
5,313
+702
+15% +$27.5K 0.02% 442
2021
Q1 		$207K Buy
+4,611
New +$257K 0.02% 409
2020
Q2 		– Sell
-41
Closed -$2K – 1664
2020
Q1 		$2K Hold
41
– – ﹤0.01% 1413
2019
Q4 		$2K Hold
41
– – ﹤0.01% 1466
2019
Q3 		$2K Sell
41
-252
-86% -$16.4K ﹤0.01% 1443
2019
Q2 		$19K Hold
293
– – ﹤0.01% 915
2019
Q1 		$24K Hold
293
– – 0.01% 758
2018
Q4 		$16K Buy
293
+62
+27% +$3.16K ﹤0.01% 825
2018
Q3 		$12K Buy
231
+27
+13% +$1.27K ﹤0.01% 983
2018
Q2 		$9K Buy
204
+163
+398% +$7.23K ﹤0.01% 1026
2018
Q1 		$2K Buy
+41
New +$2.08K ﹤0.01% 1340

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Global Retirement Partners's IONS Position: Q4 2025 in Review

Global Retirement Partners increased its Ionis Pharmaceuticals (IONS) stake by 8,057% in Q4 2025, buying an estimated $140K and bringing the position to 1,876 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #1659.

Global Retirement Partners first reported a position in IONS in Q1 2018 and has held it in 27 quarters since. The position peaked at $756K in Q2 2022. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

  • Global Retirement Partners held 1,876 shares of Ionis Pharmaceuticals worth $148K as of Q4 2025.
  • Global Retirement Partners bought 1,853 Ionis Pharmaceuticals shares in Q4 2025, an estimated $140K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #1659 holding.
  • Global Retirement Partners first reported a position in Ionis Pharmaceuticals in Q1 2018 and has held it in 27 quarters since.
  • Global Retirement Partners's Ionis Pharmaceuticals position peaked at $756K in Q2 2022.
  • 491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.